Randomised, controlled trial of faecal occult blood screening for colorectal cancer. Results for first 107,349 subjects.
about
GastroenterologyResults of screening, rescreening, and follow-up in a prospective randomized study for detection of colorectal cancer by fecal occult blood testing. Results for 68,308 subjectsIdentification of serum biomarkers for colon cancer by proteomic analysisFecal occult blood testing for colorectal cancer in an ethnically diverse populationChemical and immunological testing for faecal occult blood in screening subjects at risk of familial colorectal cancer.Screening for colorectal cancer: reasons for refusal of faecal occult blood testing in a general practice in EnglandThe effect on compliance of a health education leaflet in colorectal cancer screening in general practice in central England.The cost of screening for colorectal cancer.Choosing quality of care measures based on the expected impact of improved care on health.MALDI-TOF MS combined with magnetic beads for detecting serum protein biomarkers and establishment of boosting decision tree model for diagnosis of colorectal cancer.A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, hemoccultScreening for colorectal cancer using the faecal occult blood test, hemoccult.Screening for colorectal cancer: a general-practice-based study.Cancer screening trials: nuts and bolts.Periodic health examination, 1994 update: 2. Screening strategies for colorectal cancer. Canadian Task Force on the Periodic Health ExaminationImplementation of population screening for colorectal cancer by repeated Fecal Immunochemical Test (FIT): third round.Patient compliance with colorectal cancer screening in general practiceHaemoccult does not reduce the need for colonoscopy in surveillance after curative resection for colorectal cancer.Feasibility of family based screening for colorectal neoplasia: experience in one general surgical practiceRole of upper gastrointestinal investigations in a screening study for colorectal neoplasiaScreening for gastrointestinal cancer: an epidemiological review.Longitudinal predictors of colorectal cancer screening among participants in a randomized controlled trial.Colorectal cancer screening in asymptomatic populations.Family based colorectal cancer screening in a district hospitalAberrant methylation of NPY, PENK, and WIF1 as a promising marker for blood-based diagnosis of colorectal cancerAre physicians' recommendations for colorectal cancer screening guideline-consistent?Colorectal cancer: what the clinician wants to know.Effect of aspirin and non-steroidal anti-inflammatory drugs on colorectal adenomas: case-control study of subjects participating in the Nottingham faecal occult blood screening programmeScreening and genetic counselling for relatives of patients with colorectal cancer in a family cancer clinic.As tests evolve and costs of cancer care rise: reappraising stool-based screening for colorectal neoplasiaEndoscopic screening of relatives of patients with colorectal cancer.Effect of faecal occult blood screening on mortality from colorectal cancer: results from a randomised controlled trial.Acceptability of opportunistic screening for occult gastrointestinal blood loss.Colorectal adenomas and diet: a case-control study of subjects participating in the Nottingham faecal occult blood screening programmeScreening and the costs of treating colorectal cancer.Is screening for colorectal cancer worthwhile?Genetic Variants Associated with Colorectal Adenoma Susceptibility.The effect of calcium supplements on rectal mucosal proliferation.Haemoccult test properties according to type and number of positive slides in mass screening for colorectal cancer.General practitioners' perceptions of population based bowel screening and their influence on practice: a qualitative study
P2860
Q27486369-A19E4025-B2CB-4618-83AA-35161E042960Q28245334-AF3B34F2-BEA6-4528-8E5E-FDDA9E62A390Q33245826-3670D8CD-7421-4C10-A5D6-CC1F4A8CAD3CQ33608108-6D9B8863-DEA6-4C08-865C-C25B23074D67Q33617711-E1797D8F-1919-4220-A902-133415C1C474Q33702845-D55869AB-7642-43FF-AC2F-224A3ACC8EAAQ33704237-D70E4990-A397-47E5-AFB1-C649D343D17DQ33705473-C19B43B4-D390-47D8-8F36-106C02AEB786Q33725005-DFCCFB81-776C-4706-9CD3-107172A6DDB7Q33793178-515DECD7-035E-4205-949E-4C8D4EFCD332Q33830589-FE5C6789-EE25-4D59-93FE-14C9724B8BB6Q33909701-D5A56450-57CB-44C7-A3B2-DB86951AD4BCQ34054807-FF299262-1B29-41CE-8DC4-F53E769C9A13Q34073143-3554218A-AD79-4C21-BF57-ED5F53A08F59Q34276834-EB5285C4-5857-4035-98B5-40F902A3AE25Q34309092-96E9BC71-EDE4-4407-9D5D-C80D3214ABA5Q34370123-D8D4E517-FCCB-45AC-9E81-A116494CE8BEQ34375566-6C901E7A-A210-4B57-9306-980644FD5616Q34376274-E772EECC-F7C3-4615-BD3B-8AF865EA9CA6Q34393082-63C3AE2B-F88B-487C-B9C0-69FF2BEAE9C7Q34393466-E06C5654-A862-4EEB-A6C3-346CCC2AB8C6Q34403734-CF882006-9B40-492A-BCF8-54E1C4C11994Q34407857-D86DE9C8-6E0F-4C0F-9A5B-A78514ACEAA1Q34409471-6D438762-BE28-43FE-8CAC-5D4DA85C0A29Q34449043-BFDA1C38-13BE-4EE9-B706-8485CE947D11Q34482496-DC63BCED-9DAC-4005-8CBC-70184107DCA5Q35173102-A42FEBF9-135B-417E-84EA-654D68EE0A14Q35189272-030F22BB-3629-4D0A-8216-D55391CEA177Q35191492-675F536E-7C5E-48BE-914D-219FC257D29CQ35206019-0FEC6C2A-7089-4E75-B8B7-22F01F8E8F2EQ35348983-457D1B52-3BCF-4932-803D-6ABB7B5C0033Q35594657-7809E55D-1F4B-4E0C-8FC3-2B722A041D6AQ35819796-C1C112D5-2E01-426C-88E0-4745FD1BD6EDQ35975901-6BFE8235-6F56-4CBF-AF5E-CB0A86651460Q35977843-DD71B33F-FACA-4B23-B0D7-3119F884B613Q35982843-2DFC0406-F7C9-4418-A8D0-0AC76756073EQ35990039-4E0AEA0D-4BF2-477B-939A-7CD44E256503Q36079888-F2ADCB2D-52EA-4029-9042-D97E1CF2C954Q36081665-8B1A3601-D55E-40DA-BA4F-F6398FB5E6F2Q36309560-5E3C45B2-6BAE-42AB-AE78-0638B404A65E
P2860
Randomised, controlled trial of faecal occult blood screening for colorectal cancer. Results for first 107,349 subjects.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh
1989年學術文章
@zh-hant
name
Randomised, controlled trial o ...... ts for first 107,349 subjects.
@en
Randomised, controlled trial o ...... ts for first 107,349 subjects.
@nl
type
label
Randomised, controlled trial o ...... ts for first 107,349 subjects.
@en
Randomised, controlled trial o ...... ts for first 107,349 subjects.
@nl
prefLabel
Randomised, controlled trial o ...... ts for first 107,349 subjects.
@en
Randomised, controlled trial o ...... ts for first 107,349 subjects.
@nl
P2093
P1433
P1476
Randomised, controlled trial o ...... ts for first 107,349 subjects.
@en
P2093
J Chamberlain
J D Hardcastle
J Sheffield
N C Armitage
T W Balfour
W M Thomas
P304
P356
10.1016/S0140-6736(89)92750-5
P407
P577
1989-05-01T00:00:00Z